Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia

PURPOSE: To examine the impact of newly initiated pregabalin or duloxetine treatment on fibromyalgia (FM) patients’ encounters with potential drug–drug interactions (DDIs), the health care cost and utilization consequences of those interactions, and the impact of treatment on opioid utilization. PAT...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ellis, Jeffrey J, Sadosky, Alesia B, Ten Eyck, Laura L, Cappelleri, Joseph C, Brown, Courtney R, Suehs, Brandon T, Parsons, Bruce
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2014
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4204911/
https://ncbi.nlm.nih.gov/pubmed/25339847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S66759
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak